193 related articles for article (PubMed ID: 12618758)
1. An unexpected role for FosB in activation-induced cell death of T cells.
Baumann S; Hess J; Eichhorst ST; Krueger A; Angel P; Krammer PH; Kirchhoff S
Oncogene; 2003 Mar; 22(9):1333-9. PubMed ID: 12618758
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the AP-1 sites in the IL-2 promoter.
Jain J; Valge-Archer VE; Rao A
J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937
[TBL] [Abstract][Full Text] [Related]
3. Involvement of phospholipase D in the activation of transcription factor AP-1 in human T lymphoid Jurkat cells.
Mollinedo F; Gajate C; Flores I
J Immunol; 1994 Sep; 153(6):2457-69. PubMed ID: 8077660
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events.
Latinis KM; Carr LL; Peterson EJ; Norian LA; Eliason SL; Koretzky GA
J Immunol; 1997 May; 158(10):4602-11. PubMed ID: 9144472
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter.
Parra E; McGuire K; Hedlund G; Dohlsten M
J Immunol; 1998 Jun; 160(11):5374-81. PubMed ID: 9605137
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the human death receptor 4 is regulated by activator protein 1.
Guan B; Yue P; Lotan R; Sun SY
Oncogene; 2002 May; 21(20):3121-9. PubMed ID: 12082627
[TBL] [Abstract][Full Text] [Related]
7. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
Li-Weber M; Laur O; Dern K; Krammer PH
Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation.
Melino G; Bernassola F; Catani MV; Rossi A; Corazzari M; Sabatini S; Vilbois F; Green DR
Cancer Res; 2000 May; 60(9):2377-83. PubMed ID: 10811113
[TBL] [Abstract][Full Text] [Related]
9. An activation-responsive element in single C motif-1/lymphotactin promoter is a site of constitutive and inducible DNA-protein interactions involving nuclear factor of activated T cell.
Yoshida T; Ishikawa I; Ono Y; Imai T; Suzuki R; Yoshie O
J Immunol; 1999 Sep; 163(6):3295-303. PubMed ID: 10477599
[TBL] [Abstract][Full Text] [Related]
10. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.
Eichhorst ST; Müller M; Li-Weber M; Schulze-Bergkamen H; Angel P; Krammer PH
Mol Cell Biol; 2000 Oct; 20(20):7826-37. PubMed ID: 11003676
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
[TBL] [Abstract][Full Text] [Related]
12. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway.
Ouafik L; Berenguer-Daize C; Berthois Y
Cell Signal; 2009 Apr; 21(4):597-608. PubMed ID: 19166930
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-kappaB in regulated expression.
Kang NY; Kang SK; Lee YC; Choi HJ; Lee YS; Cho SY; Kim YS; Ko JH; Kim CH
Glycobiology; 2006 May; 16(5):375-89. PubMed ID: 16481330
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha.
Gorak-Stolinska P; Truman JP; Kemeny DM; Noble A
J Leukoc Biol; 2001 Nov; 70(5):756-66. PubMed ID: 11698496
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
17. A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes.
Norian LA; Latinis KM; Koretzky GA
J Immunol; 1998 Aug; 161(3):1078-82. PubMed ID: 9686564
[TBL] [Abstract][Full Text] [Related]
18. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
19. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
